OrbiMed Advisors LLC's Form 4 filing
Traws Pharma, Inc. (TRAW) · filed Apr 28, 2026
- Accession no.
- 0000947871-26-000481
- Filed
- Apr 28, 2026, 9:41 PM ET
- Trade date
- Apr 16, 2026
- Filing delay
- 12 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 3 derivative transactions. Open-market purchases total $998.2K. It was filed 12 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VIII LLCCIK 0001845804 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock | PPurchaseAcquired | +597,729 | $1.67 | +$998,207.43 | 1,203,250 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock | PPurchaseAcquired | +597,729 | – | – | 597,729 | Indirect | |
| Apr 16, 2026 | Common Stock | PPurchaseAcquired | +597,729 | – | – | 597,729 | Indirect | |
| Apr 16, 2026 | Common Stock | PPurchaseAcquired | +1,793,187 | – | – | 1,793,187 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.